학술논문
Neoadjuvant anthracycline-based (5-FEC) or anthracycline-free (docetaxel/carboplatin) chemotherapy plus trastuzumab and pertuzmab in HER2+BC patients according to their TOP2A: a multicentre, open-label, non-randomized phase II trial
Document Type
Journal
Author
Ginzac, Angeline; Molnar, Ioana; Durando, Xavier; De La Motte Rouge, Thibault; Petit, Thierry; D'hondt, Veronique; Campone, Mario; Bonichon-Lamichhane, Nathalie; Venat Bouvet, Laurence; Levy, Christelle; Augereau, Paule; Pistilli, Barbara; Arsene, Olivier; Nguyen, Suzanne; Jouannaud, Christelle; Cayre, Anne; Tixier, Lucie; Mahier Ait Oukhatar, Celine; Nabholtz, Jean-Marc; Penault-Llorca, Frederique; Mouret-Reynier, Marie-Ange
Source
Subject
Language
English
ISSN
15737217